Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
See Latest ArticlesInterplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils
Journal of Leukocyte Biology, 08/07/09
Svensson L et al. – Pharmacologic inhibition of signal transduction molecules showed that the release of free oxygen radicals in response to eotaxin–1 compared with fMLP is relatively more dependent on the p38 MAPK pathway.
Related Articles
Inhibition of eosinophil migration by lactoferrin
Immunology & Cell Biology, 11/19/09
Relevance Score: 89%
The effects of anti-asthma drugs on the phagocytic clearance of apoptotic eosinophils by A549 cells
Respiratory Medicine, 10/07/09
Relevance Score: 89%
Multiple tiny granulomatous lesions with eosinophils in a patient with smoldering-type adult T-cell leukaemia: The possibility of a new type of bronchioloalveolopathy
Respirology, 11/10/09
Relevance Score: 84%
Bromotyrosines in sputum proteins and treatment effects of terbutaline and budesonide in asthma
Annals of Allergy, Asthma, and Immunology, 10/15/09
Relevance Score: 84%
IL-5- and eosinophil-mediated inflammation: from discovery to therapy
International Immunology, 10/12/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Can antigen-specific regulatory T cells protect against graft vs. host disease and spare anti-malignancy alloresponse
Haematologica, 12/18/09
Mutiny on the Boun-T: Controlling Dangerous T Cells Through Anergy
Discovery Medicine, 12/17/09
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
Breast Cancer Research and Treatment, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor